PeptidePedia The community reference

Adverse effects of GLP-1 receptor agonists: difference between revisions

Diff·revision 17 → 18·00:11, 18 Jan 2025

Difference between revision 17 and revision 18 of Adverse effects of GLP-1 receptor agonists. This revision changed no lines of source — the edit was a null or whitespace change.

Revision 17 — 18:44, 1 Jan 2025
SarcopeniaSefa (talk)
ce
4,482 bytes +353
Revision 18 — 00:11, 18 Jan 2025
PancreasPru (talk)
expand §Less common but significant
4,482 bytes ±0
No change to the page source.